ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancer

Wang, Lijuan; Tang, Ganghua; Hu, Kongzhen; Liu, Xinran; Zhou, Wenlan; Li, Hongsheng; Huang, Shun; Han, Yanjiang; Chen, Li; Zhong, Jinmei; Wu, Hubing*南方医科大学
RADIOLOGY2022-4DOI: 10.1148/radiol.211424
53被引11阅读
引用收藏
分享

摘要

Background: Gallium 68 (Ga-68)-labeled fibroblast-activation protein inhibitor (FAPI) has recently been-introduced as a promising tumor imaging agent. @@@ Purpose: To compare Ga-68-FAPI PET/CT with fluorine 18 (F-18)-labeled fluorodeoxyglucose (FDG) PET/CT in evaluating lung cancer. Materials and @@@ Methods: In this prospective study conducted from September 2020 to February 2021, images from participants with lung cancer who underwent both Ga-68-FAPI and F-18-FDG PET/CT examinations were analyzed. The tracer uptakes, quantified by maximum standardized uptake value (SUVmax) and target-to-background ratio (TBR), were compared for paired positive lesions between both modalities using the paired t test or Wilcoxon signed-rank test. @@@ Results: Thirty-four participants (median age, 64 years [interquartile range: 46-80 years]; 20 men) were evaluated. From visual evaluation, Ga-68-FAPI PET/CT and F-18-FDG PET/CT showed similar performance in the delineation of primary tumors and detection of suspected metastases in the lungs, liver, and adrenal glands. The metabolic tumor volume in primary and recurrent lung tumors showed no difference between modalities (mean: 11.6 vs 10.8, respectively; P = .68). However, compared with 18F-FDG PET/CT, Ga-68-FAPI PET/CT depicted more suspected metastases in lymph nodes (356 vs 320), brain (23 vs 10), bone (109 vs 91), and pleura (66 vs 35). From semiquantitative evaluation, the SUVmax and TBR of primary or recurrent tumors, positive lymph nodes, bone lesions, and pleural lesions at Ga-68-FAPI PET/CT were all higher than those at F-18-FDG PET/CT (all P < .01). Although SUVmax of Ga-68-FAPI and F-18-FDG in brain metastases were not different (mean SUVmax: 9.0 vs 7.4, P = .32), TBR was higher with Ga-68-FAPI than with F-18-FDG (mean: 314.4 vs 1.0, P = .02). @@@ Conclusion: Gallium 68-labeled fibroblast-activation protein inhibitor PET/CT may outperform fluorine 18-labeled fluorodeoxyglucose PET/CT in staging lung cancer, particularly in the detection of metastasis to the brain, lymph nodes, bone, and pleura.

学科与关键词

关键词
BONE METASTASESCELLDIAGNOSISACCURACYPATIENTCT
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
RADIOLOGY
发表日期
2022-04
卷期
第 303 卷, 第 1 期
页码
191-199
DOI
10.1148/radiol.211424
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation Project of China [81873905, 91949121]; Nanfang Hospital Talent Introduction Foundation of Southern Medical University [123456]

作者

  • W

    Wang, Lijuan (第一作者)

    southern med univ

  • T

    Tang, Ganghua

    southern med univ

查看全部 11 位作者收起作者
  • H

    Hu, Kongzhen

    southern med univ

  • L

    Liu, Xinran

    southern med univ

  • Z

    Zhou, Wenlan

    southern med univ

  • L

    Li, Hongsheng

    southern med univ

  • H

    Huang, Shun

    southern med univ

  • H

    Han, Yanjiang

    southern med univ

  • C

    Chen, Li

    southern med univ

  • Z

    Zhong, Jinmei

    southern med univ

  • W

    Wu, Hubing (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417